EFFICACY AND SAFETY OF SMECTA COMBINED WITH ORAL REHYDRATION IN THE TREATMENT OF ACUTE DIARRHEA IN CHILDRE

IVERSIDAD PERUANA CAYETANO HEREDIA,0 个研究点目标入组 0 人开始时间: 2001年12月28日最近更新: 2023年9月4日

研究概览

暂无简介。

•The authorization statement, before completing any procedure related to the study, must be dated and signed by the accompanying adult and a witness (who could be a member of the medical team).
•Age between 1 and 36 months (inclusive).
•Acute watery diarrhea defined by a minimum of 3 watery intestinal activities per day for less than 72 hours.
•Need for oral rehydration, according to WHO criteria

•Current episode of diarrhea previously treated with any antidiarrheal medication.
•Diarrhea caused by medications (eg antibiotic therapy administered the week before entry into the study).
•History of a recent episode (2 weeks) of diarrhea.
•History of persistent diarrhea (> 4 loose stools per day for> 14 days).
•Dense blood in the stools.
•Disease of poor assimilation diagnosed previously.
•Severe dehydration requiring IV therapy, according to WHO criteria.
•Child fed exclusively by breastfeeding.
•Inability to drink.
•Fever> 39 ° C,
•History of illness that requires concomitant treatment.
•Clinical evidence of another disease that requires antibiotic therapy.
•You are currently receiving antibiotic therapy and / or an antidiarrheal agent.
•Weight - height ratio <80%, (average value).
•Child who has been previously included in this study or any other clinical trial completed less than one month ago.

发起方

IVERSIDAD PERUANA CAYETANO HEREDIA,